Bioventus Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Public

  • Employees
  • 960

Employees

  • Stock Symbol
  • BVS

Stock Symbol

  • Investments
  • 12

  • Share Price
  • $9.88
  • (As of Friday Closing)

Bioventus General Information

Description

Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly PE-Backed
Corporate Office
  • 4721 Emperor Boulevard
  • Suite 100
  • Durham, NC 27703
  • United States
Primary Industry
Diagnostic Equipment
Other Industries
Medical Supplies
Therapeutic Devices
Stock Exchange
NAS
Vertical(s)
Corporate Office
  • 4721 Emperor Boulevard
  • Suite 100
  • Durham, NC 27703
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Bioventus Stock Performance

As of 20-Nov-2026, Bioventus’s stock price is $9.88. Its current market cap is $677M with 68.5M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$9.88 $9.95 $6.47 - $15.89 $677M 68.5M 540K $0.85

Bioventus Financials Summary

As of 30-Sep-2026, Bioventus has a trailing 12-month revenue of $586M.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 1,199,100 819,884 1,064,970 748,547
Revenue 585,639 568,087 573,280 512,345
EBITDA 101,743 99,206 36,005 (23,070)
Net Income 57,296 22,732 (36,125) (156,230)
Total Assets 673,430 683,559 727,956 810,910
Total Debt 229,827 293,951 335,627 394,846
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Bioventus Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Bioventus‘s full profile, request access.

Request a free trial

Bioventus Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address
Diagnostic Equipment
Durham, NC
960 As of 2026

Lewisville, TX
 

Mölndal, Sweden
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Bioventus Competitors (20)

One of Bioventus’s 20 competitors is Orthofix Medical, a Formerly PE-Backed company based in Lewisville, TX.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Orthofix Medical Formerly PE-Backed Lewisville, TX
Mölnlycke Health Care Private Equity-Backed Mölndal, Sweden
Performance Health Holding Private Equity-Backed Downers Grove, IL
MicroPort Scientific Formerly VC-backed Shanghai, China
Exactech Formerly PE-Backed Gainesville, FL
You’re viewing 5 of 20 competitors. Get the full list »

Bioventus Patents

Bioventus Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-202511799-D0 Wound filler Pending 21-Jul-2025
GB-202510930-D0 Dressing status monitoring and exudate fill determination Inactive 07-Jul-2025
GB-202507025-D0 Conformable and separable printed circuit board assemblies for negative pressure wound therapy system Pending 08-May-2025
GB-202502322-D0 Dressing fixture and method Pending 17-Feb-2025
GB-202414397-D0 Negative and/or positive pressure therapy devices and methods with natural language interfaces Pending 01-Oct-2024
To view Bioventus’s complete patent history, request access »

Bioventus Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Bioventus Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Bioventus‘s full profile, request access.

Request a free trial

Bioventus Investments & Acquisitions (12)

Bioventus’s most recent deal was a Merger/Acquisition with CartiHeal for . The deal was made on 12-Jul-2022.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
CartiHeal 12-Jul-2022 Merger/Acquisition Therapeutic Devices
Misonix 29-Oct-2021 Merger/Acquisition Surgical Devices
Trice Medical 25-Aug-2021 Later Stage VC Surgical Devices
Vaporox 16-Aug-2021 Later Stage VC Therapeutic Devices
Bioness 30-Mar-2021 Merger/Acquisition Therapeutic Devices
You’re viewing 5 of 12 investments and acquisitions. Get the full list »

Bioventus ESG

Risk Overview

Risk Rating

Updated November, 17, 2026

31.17 | High Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 13,593

Rank

Percentile

Healthcare

Industry

of 590

Rank

Percentile

Medical Devices

Subindustry

of 209

Rank

Percentile

To view Bioventus’s complete esg history, request access »

Bioventus Exits (6)

Bioventus’s most recent exit was on 12-Jul-2022 from CartiHeal. The exit was categorized as .

Company Name Exit Date Exit Type Exit Size Status Buyers
CartiHeal 12-Jul-2022 Completed
Bioness 30-Mar-2021 Completed
CartiHeal 16-Jul-2020 Completed
  • 4 buyers
CartiHeal 31-Jan-2018 Completed
  • 5 buyers
BMP Development Program 01-Jul-2013 Buyout/LBO Completed
  • 5 buyers
You’re viewing 5 of 6 exits. Get the full list »

Bioventus Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Perseus Intermediate Durham, NC 2021

Bioventus FAQs

  • When was Bioventus founded?

    Bioventus was founded in 2012.

  • Where is Bioventus headquartered?

    Bioventus is headquartered in Durham, NC.

  • What is the size of Bioventus?

    Bioventus has 960 total employees.

  • What industry is Bioventus in?

    Bioventus’s primary industry is Diagnostic Equipment.

  • Is Bioventus a private or public company?

    Bioventus is a Public company.

  • What is Bioventus’s stock symbol?

    The ticker symbol for Bioventus is BVS.

  • What is the current stock price of Bioventus?

    As of 20-Nov-2026 the stock price of Bioventus is $9.88.

  • What is the current market cap of Bioventus?

    The current market capitalization of Bioventus is $677M.

  • What is Bioventus’s current revenue?

    The trailing twelve month revenue for Bioventus is $586M.

  • Who are Bioventus’s competitors?

    Orthofix Medical, Mölnlycke Health Care, Performance Health Holding, MicroPort Scientific, and Exactech are some of the 20 competitors of Bioventus.

  • What is Bioventus’s annual earnings per share (EPS)?

    Bioventus’s EPS for 12 months was $0.85.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process